China Regenerative Medicine International Limited (HKG:8158)

HKG:8158 Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.7	3.33	1.85	9.93	4.77
Cash & Short-Term Investments	22.7	3.33	1.85	9.93	4.77
Cash Growth	580.92%	80.31%	-81.38%	108.29%	-98.48%
Accounts Receivable	0.62	1.2	0.07	0.21	0.08
Other Receivables	28.02	156.43	237.71	196.91	116.89
Receivables	28.64	157.63	237.78	197.12	116.97
Inventory	0.24	0.45	0.29	0.38	1.38
Prepaid Expenses	0.16	0.19	2.56	41.36	8.6
Other Current Assets	6.58	6.99	6.62	9.59	11.9
Total Current Assets	58.31	168.58	249.09	258.39	143.62
Property, Plant & Equipment	6.99	17.32	26.82	0.75	1.3
Other Long-Term Assets	70.41	-	-	-	7.57
Total Assets	135.71	185.9	275.91	259.14	152.49
Accounts Payable	3.84	2.47	0.05	0.09	8
Accrued Expenses	8.67	13.11	7.65	3.71	13.74
Current Portion of Long-Term Debt	3.63	13.63	48.41	29.95	20.3
Current Portion of Leases	4.59	10.4	9.92	5.87	17.03
Current Income Taxes Payable	24.87	25.29	25.57	24.26	12.56
Current Unearned Revenue	11.29	81.09	60.74	76.6	9.16
Other Current Liabilities	1.98	1.81	5.82	6.83	120.31
Total Current Liabilities	58.87	147.79	158.17	147.31	201.1
Long-Term Debt	45.47	21.58	-	-	-
Long-Term Leases	-	4.59	13.68	-	5.87
Long-Term Deferred Tax Liabilities	0.15	0.15	0.15	0.1	0.67
Other Long-Term Liabilities	6.02	-	-	-	-
Total Liabilities	110.51	174.1	172	147.41	207.64
Common Stock	60.85	60.85	570.86	570.86	570.86
Additional Paid-In Capital	3,216	3,216	3,204	3,204	3,204
Retained Earnings	-2,863	-2,881	-3,287	-3,292	-3,305
Comprehensive Income & Other	-388.23	-383.88	-383.46	-371.09	-411.34
Total Common Equity	25.2	11.79	103.92	111.73	58.13
Minority Interest	-	-	-	-	-113.28
Shareholders' Equity	25.2	11.79	103.92	111.73	-55.15
Total Liabilities & Equity	135.71	185.9	275.91	259.14	152.49
Total Debt	53.69	50.19	72.01	35.82	43.19
Net Cash (Debt)	-30.99	-46.86	-70.16	-25.9	-38.43
Net Cash Per Share	-0.10	-0.16	-0.25	-0.09	-0.24
Filing Date Shares Outstanding	304.25	304.25	285.43	285.43	285.43
Total Common Shares Outstanding	304.25	304.25	285.43	285.43	285.43
Working Capital	-0.56	20.79	90.93	111.08	-57.48
Book Value Per Share	0.08	0.04	0.36	0.39	0.20
Tangible Book Value	25.2	11.79	103.92	111.73	58.13
Tangible Book Value Per Share	0.08	0.04	0.36	0.39	0.20
Machinery	6.44	6.47	53.66	53.4	53.89
Leasehold Improvements	22.19	21.74	104.15	101.82	101.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.